Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Together, these three mechanisms are thought to create a synergistic effect on body weight and metabolic health
Rising awareness among healthcare professionals regarding the long-term benefits of GLP-1 receptor agonists for weight reduction and cardiovascular health is contributing to market growth
Unlike most of the companies in our ranks, BI actually increased its workforce in 2007, adding 1,400 people
Patients lost an average of 20.2% of their body weight on tirzepatide versus 13.7% on semaglutide after 72 weeks (Source: SURMOUNT-5 Trial, Wharton et al., NEJM 2025)
.jpg)
US$ 28.88
US$ 28.45
US$ 23.91
